US Bancorp’s HOOKIPA Pharma HOOK Stock Holding History

US Bancorp’s Portfolio HOOK Stock Details HOOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-150	Closed	-$924	–	4052
2023 Q3	$924	Hold	150	–	–	﹤0.01%	3782
2023 Q2	$1.32K	Hold	150	–	–	﹤0.01%	3773
2023 Q1	$1.1K	Hold	150	–	–	﹤0.01%	3853
2022 Q4	$1.22K	Hold	150	–	–	﹤0.01%	3888
2022 Q3	$2K	Hold	150	–	–	﹤0.01%	3830
2022 Q2	$2K	Hold	150	–	–	﹤0.01%	3830
2022 Q1	$3K	Hold	150	–	–	﹤0.01%	3741
2021 Q4	$3K	Hold	150	–	–	﹤0.01%	3800
2021 Q3	$9K	Hold	150	–	–	﹤0.01%	3477
2021 Q2	$14K	Hold	150	–	–	﹤0.01%	3289
2021 Q1	$20K	Buy	150 +75	+100%	+$9.05K	﹤0.01%	3026
2020 Q4	$8K	Hold	75	–	–	﹤0.01%	3257
2020 Q3	$7K	Hold	75	–	–	﹤0.01%	3194
2020 Q2	$9K	Hold	75	–	–	﹤0.01%	3126
2020 Q1	$6K	Buy	+75	New	+$8.21K	﹤0.01%	3186

Other funds holding HOOK

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

US Bancorp's HOOK Position: Q4 2023 in Review

US Bancorp sold out of HOOKIPA Pharma (HOOK) in Q4 2023, closing a stake of 150 shares — an estimated $924 sold.

US Bancorp first reported a position in HOOK in Q1 2020 and held it in 15 quarters. The position peaked at $20K in Q1 2021. 41 funds tracked by Wall St. Rank hold HOOK as of Q4 2023.

US Bancorp reported no remaining HOOKIPA Pharma position as of Q4 2023 after selling out during the quarter.
US Bancorp sold 150 HOOKIPA Pharma shares in Q4 2023, an estimated $924.
US Bancorp first reported a position in HOOKIPA Pharma in Q1 2020 and held it in 15 quarters.
US Bancorp's HOOKIPA Pharma position peaked at $20K in Q1 2021.
41 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q4 2023.

Based on US Bancorp's 13F filing for Q4 2023, filed 9 Feb 2024.